The Health Research Authority has backed the researchers behind a large-scale study of treatments for chronic fatigue syndrome, after concerns were raised about their conduct.
The HRA, the body responsible for overseeing the ethics and transparency of health and social care research, said in a letter to the House of Commons Science and Technology Committee released on 6 February that there were “no regulatory concerns about the conduct of the investigators” involved in the £5-million PACE trial.
The letter from Jonathan Montgomery, chair of the HRA, comes months after Carol Monaghan, Scottish National Party MP for Glasgow North West, raised concerns regarding research transparency in the trial at a committee hearing as part of an inquiry on research integrity. Montgomery says the HRA looked into these and other concerns that were raised with it directly by others.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.